Abstract:Eucalyptol (1,8‐cineol), the major ingredient in the essential oil of the eucalyptus leaves and other medicinal plants, has long been known for its anti‐inflammatory properties. Eucalyptol interacts with Transient Receptor Potential (TRP) ion channels among other targets, but it is unclear which of these mediates its anti‐inflammatory effects. In this work, the effects of eucalyptol were compared in WT and TRPM8‐deficient mice in a model of pulmonary inflammation following intranasal administration of lipopolysaccharide (LPS). LPS, a component of Gram‐negative bacterial cell walls, plays a major role in acute lung injury (ALI) and acute respiratory distress syndrome (ARDS). 24 hours after LPS intranasal instillation lungs and bronchoalvelolar lavage (BAL) were collected and analyzed for leukocyte infiltration, enzyme activities and cytokine/chemokine levels by qPCR, Luminex and cell counting among other techniques. Our results show that eucalyptol treatment diminished leukocyte infiltration, myeloperoxidase activity and production of TNF‐α, IL‐1β, IFN‐γ and IL‐6. Genetic deletion of TRPM8 abolishes the anti‐inflammatory effects of eucalyptol in the LPS model. Eucalyptol is at least 30‐fold more potent on human TRPM8 than on mouse TRPM8, and a metabolite of eucalyptol, 2‐hydroxy‐1,8‐cineol, also activates human TRPM8. This shows that among the pharmacological targets of eucalyptol, TRPM8 is essential for its anti‐inflammatory effects in mice, likely mediated by peripheral sensory neurons. The much higher sensitivity of human TRPM8 to eucalyptol compared to the rodent orthologues explains the higher potency of eucalyptol in humans. Metabolites of eucalyptol likely contribute to the anti‐inflammatory effects. The development of more potent and selective TRPM8 agonists may yield novel anti‐inflammatory therapeutics. Support or Funding Information ‐ NIH grants R01HL105635 and R01HL105635‐S1 (to S. E. J. and J. B. M.) ‐ P50DA036151 project #1 (to S.E.J.).

TRPM8 Mediates the Anti‐inflammatory Effects of Eucalyptol in a Mouse Model of LPS‐Induced Pulmonary Inflammation